National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/10/2021 release of VAERS data:

This is VAERS ID 1415902



Case Details

VAERS ID: 1415902 (history)  
Form: Version 2.0  
Age: 34.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-06-04
Onset:2021-06-04
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-06-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Arthralgia, Decreased appetite, Headache, Pyrexia, SARS-CoV-2 test, Vaccination site pain
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arthritis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LEMSIP MAX
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cold; Common cold; Lactation decreased
Allergies:
Diagnostic Lab Data: Test Date: 20210526; Test Name: COVID-19 virus test; Test Result: Negative ; Comments: No - Negative COVID-19 test
CDC Split Type: GBPFIZER INC2021657563

Write-up: joint pain; High temperature; Injection site muscle pain; Generalized joint pain; Headache; Decreased appetite; This is a spontaneous report from a contactable consumer received from the regulatory authority report number is GB-MHRA-WEBCOVID-202106051430043410-ENHLB, Safety Report Unique Identifier GB-MHRA-ADR 25425944.A 34-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Jun2021 (Lot number was not reported) as 1st dose, single dose for covid-19 immunisation. Medical history included Lactation decreased, cold, Common cold. Had a cold ongoing for 3 weeks at time of vaccine being administered. Patient has not had symptoms associated with COVID-19. Patient is not enrolled in clinical trial. Patient is not pregnant, Patient is not currently breastfeeding.Concomitant medication(s) included paracetamol, phenylephrine hydrochloride (LEMSIP MAX) taken for nasopharyngitis from 16May2021 to an unspecified stop date. The patient experienced joint pain on an unspecified date with outcome of unknown, high temperature on 04Jun2021 with outcome of not recovered, injection site muscle pain on 04Jun2021 with outcome of not recovered, generalized joint pain on 04Jun2021 with outcome of not recovered, headache on 04Jun2021 with outcome of recovering, decreased appetite on 04Jun2021 with outcome of not recovered.The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 26May2021, No - Negative COVID-19 test. Case Narrative: The joint pain and headache are sufficient that she cannot move without significant difficulty. Patient has not tested positive for COVID-19 since having the vaccine. All events were marked as medically significant. No follow-up attempts are possible, information about batch number cannot be obtained. No further information is expected.


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1415902


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166